Summary & Overview
HCPCS P7001: Quantitative Bacterial Urine Culture with Sensitivity
HCPCS Level II code P7001 denotes a quantitative bacterial urine culture with antimicrobial sensitivity testing, a commonly ordered microbiology diagnostic that guides treatment for suspected urinary tract infections and septic evaluations. Nationally, urine culture with susceptibility is a key component of laboratory services used across inpatient and outpatient settings to support appropriate antimicrobial selection and infection management.
Key payers covered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and service setting for P7001, plus what to expect from payer coverage patterns and common billing considerations. The publication highlights benchmarks related to utilization and reimbursement trends, summarizes relevant policy updates affecting laboratory services, and situates P7001 within typical clinical workflows (specimen collection, laboratory processing, and reporting of susceptibility results).
The content is intended for billing managers, laboratory directors, and policy analysts seeking a national perspective on how this laboratory procedure is coded and processed. Data not available in the input where specific payer policies, associated taxonomies, ICD-10 diagnoses, and related codes would normally be summarized.
Billing Code Overview
HCPCS Level II code P7001 describes a quantitative bacterial urine culture with sensitivity testing. The service involves culturing a urine specimen to quantify bacterial growth and performing antimicrobial susceptibility testing to identify effective antibiotics. The service type is a microbiology laboratory diagnostic test. The typical site of service is an independent clinical laboratory, hospital laboratory, or outpatient specimen collection facility.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult or pediatric patient presenting with signs or symptoms suggestive of a urinary tract infection (UTI) such as dysuria, urinary urgency, frequency, suprapubic pain, flank pain, fever, or altered mental status in an elderly patient. A clinician in an outpatient clinic, urgent care, emergency department, or inpatient ward orders a quantitative bacterial urine culture with sensitivity testing to identify the causative organism and determine antimicrobial susceptibilities. The clinical workflow: the patient provides a clean-catch midstream urine specimen (or a catheterized specimen for patients unable to void or those with indwelling catheters); the specimen is labeled and sent to the microbiology laboratory. In the lab, quantitative culture techniques are used to determine colony counts (cfu/mL) and to identify isolates; antimicrobial susceptibility testing (sensitivity study) is performed to guide targeted antibiotic therapy. Results are reported back to the treating clinician, who uses the organism identification and susceptibility profile to adjust empiric antibiotic therapy or confirm treatment selection.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Standard reporting when no special circumstance applies |
22 |